Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Nov;70(11):7535–7539. doi: 10.1128/jvi.70.11.7535-7539.1996

Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes.

Y P Tsao 1, L Y Li 1, T C Tsai 1, S L Chen 1
PMCID: PMC190821  PMID: 8892872

Abstract

Here we report that the E5 proteins of human papillomavirus type 11 (HPV-11) and HPV-16 suppressed the expression of the p21(WafI/SdiI/CipI) tumor suppressor gene in NIH 3T3 cells and immortalized human keratinocytes. The promoter activity of p21 was repressed by E5 of HPV-11 and -16, suggesting that p21 gene suppression by E5 was at the transcriptional level. Using an inducible system, we demonstrated that increased induction of HPV-11 E5 in NIH 3T3 cells and keratinocytes led to increased repression of p21 promoter activity. The repression of p21 promoter activity by a series of E5 mutants was somewhat correlated with their respective transforming activities. Previously, we and other investigators showed that the E5 proteins of HPV-11 and -16 can activate the expression of c-jun. The repression of p21 gene expression might be a mechanism of oncogene-mediated growth promotion, since the expression of c-jun also led to a reduction of the levels of p21 RNA and protein in keratinocytes. This is the first demonstration that E5 proteins of HPV-11 and -16 repress p21 gene expression, and this might be one of the mechanisms by which E5 stimulates cell proliferation. In addition, this is also the first report of c-jun repression of p21.

Full Text

The Full Text of this article is available as a PDF (218.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouvard V., Matlashewski G., Gu Z. M., Storey A., Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology. 1994 Aug 15;203(1):73–80. doi: 10.1006/viro.1994.1456. [DOI] [PubMed] [Google Scholar]
  2. Chen S. L., Han C. P., Tsao Y. P. Construction of site-specific mutants of E5A protein of HPV-11 using the polymerase chain reaction and a single mutant primer. J Virol Methods. 1993 Apr;42(1):89–94. doi: 10.1016/0166-0934(93)90179-u. [DOI] [PubMed] [Google Scholar]
  3. Chen S. L., Huang C. H., Tsai T. C., Lu K. Y., Tsao Y. P. The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch Virol. 1996;141(5):791–800. doi: 10.1007/BF01718155. [DOI] [PubMed] [Google Scholar]
  4. Chen S. L., Mounts P. Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells. J Virol. 1990 Jul;64(7):3226–3233. doi: 10.1128/jvi.64.7.3226-3233.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen S. L., Tsai T. Z., Han C. P., Tsao Y. P. Mutational analysis of human papillomavirus type 11 E5a oncoprotein. J Virol. 1996 Jun;70(6):3502–3508. doi: 10.1128/jvi.70.6.3502-3508.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen S. L., Tsao L. T., Tsao Y. P. Antisense oligodeoxynucleotides to c-jun inhibits proliferation of transformed NIH 3T3 cells induced by E5a of HPV-11. Cancer Lett. 1994 Sep 30;85(1):119–123. doi: 10.1016/0304-3835(94)90247-x. [DOI] [PubMed] [Google Scholar]
  7. Chen S. L., Tsao Y. P., Yang C. M., Lin Y. K., Huang C. H., Kuo S. W. Differential induction and regulation of c-jun, junB, junD and c-fos by human papillomavirus type 11 E5a oncoprotein. J Gen Virol. 1995 Nov;76(Pt 11):2653–2659. doi: 10.1099/0022-1317-76-11-2653. [DOI] [PubMed] [Google Scholar]
  8. Conrad M., Bubb V. J., Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol. 1993 Oct;67(10):6170–6178. doi: 10.1128/jvi.67.10.6170-6178.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Conrad M., Goldstein D., Andresson T., Schlegel R. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology. 1994 May 1;200(2):796–800. doi: 10.1006/viro.1994.1244. [DOI] [PubMed] [Google Scholar]
  10. Defeo-Jones D., Vuocolo G. A., Haskell K. M., Hanobik M. G., Kiefer D. M., McAvoy E. M., Ivey-Hoyle M., Brandsma J. L., Oliff A., Jones R. E. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts. J Virol. 1993 Feb;67(2):716–725. doi: 10.1128/jvi.67.2.716-725.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993 Nov 19;75(4):805–816. doi: 10.1016/0092-8674(93)90499-g. [DOI] [PubMed] [Google Scholar]
  12. Hawley-Nelson P., Vousden K. H., Hubbert N. L., Lowy D. R., Schiller J. T. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 1989 Dec 1;8(12):3905–3910. doi: 10.1002/j.1460-2075.1989.tb08570.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Howley P. M. Role of the human papillomaviruses in human cancer. Cancer Res. 1991 Sep 15;51(18 Suppl):5019s–5022s. [PubMed] [Google Scholar]
  14. Hwang E. S., Nottoli T., Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology. 1995 Aug 1;211(1):227–233. doi: 10.1006/viro.1995.1395. [DOI] [PubMed] [Google Scholar]
  15. Jewers R. J., Hildebrandt P., Ludlow J. W., Kell B., McCance D. J. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J Virol. 1992 Mar;66(3):1329–1335. doi: 10.1128/jvi.66.3.1329-1335.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jiang H., Lin J., Su Z. Z., Collart F. R., Huberman E., Fisher P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 1994 Nov;9(11):3397–3406. [PubMed] [Google Scholar]
  17. Leechanachai P., Banks L., Moreau F., Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene. 1992 Jan;7(1):19–25. [PubMed] [Google Scholar]
  18. Leptak C., Ramon y Cajal S., Kulke R., Horwitz B. H., Riese D. J., 2nd, Dotto G. P., DiMaio D. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J Virol. 1991 Dec;65(12):7078–7083. doi: 10.1128/jvi.65.12.7078-7083.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M., Smith J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994 Mar;211(1):90–98. doi: 10.1006/excr.1994.1063. [DOI] [PubMed] [Google Scholar]
  20. Pim D., Collins M., Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene. 1992 Jan;7(1):27–32. [PubMed] [Google Scholar]
  21. Ryder K., Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8464–8467. doi: 10.1073/pnas.85.22.8464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sherr C. J. G1 phase progression: cycling on cue. Cell. 1994 Nov 18;79(4):551–555. doi: 10.1016/0092-8674(94)90540-1. [DOI] [PubMed] [Google Scholar]
  23. Straight S. W., Hinkle P. M., Jewers R. J., McCance D. J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol. 1993 Aug;67(8):4521–4532. doi: 10.1128/jvi.67.8.4521-4532.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tsao Y. P., Chu T. Y., Chen T. M., Yang Y. F., Chen S. L. Effects of E5a and E7 genes of human papillomavirus type 11 on immortalized human epidermal keratinocytes and NIH 3T3 cells. Arch Virol. 1994;138(1-2):177–185. doi: 10.1007/BF01310049. [DOI] [PubMed] [Google Scholar]
  25. Tsao Y. P., Huang C. H., Lin Y. K., Chen S. L. Protein kinase C-and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein. Cancer Lett. 1995 Aug 16;95(1-2):201–205. doi: 10.1016/0304-3835(95)03894-3. [DOI] [PubMed] [Google Scholar]
  26. Tsao Y. P., Kuo S. W., Li S. F., Liu J. C., Lin S. Z., Chen K. Y., Chen S. L. Differential regulation of cyclin A, cyclin B and p21 concentrations in a growth-restricted human fibroblast cell line. Biochem J. 1995 Dec 15;312(Pt 3):693–698. doi: 10.1042/bj3120693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tsao Y. P., Kuo S. W., Li S. F., Tsai T. C., Li L. Y., Chen S. L. Human papillomavirus 11 E5a delays the growth restriction induced by temperature shift in temperature-sensitive simian virus 40 T antigen-immortalized keratinocytes. Biochem Biophys Res Commun. 1995 Dec 26;217(3):712–720. doi: 10.1006/bbrc.1995.2831. [DOI] [PubMed] [Google Scholar]
  28. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993 Dec 16;366(6456):701–704. doi: 10.1038/366701a0. [DOI] [PubMed] [Google Scholar]
  29. Xiong Y., Zhang H., Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 1993 Aug;7(8):1572–1583. doi: 10.1101/gad.7.8.1572. [DOI] [PubMed] [Google Scholar]
  30. el-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994 Mar 1;54(5):1169–1174. [PubMed] [Google Scholar]
  31. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993 Nov 19;75(4):817–825. doi: 10.1016/0092-8674(93)90500-p. [DOI] [PubMed] [Google Scholar]
  32. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 1991 Sep;184(1):9–13. doi: 10.1016/0042-6822(91)90816-t. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES